A 96-year-old woman with inherited type 2A von Willebrand disease and previously mild symptoms experienced a sudden worsening of bleeding after developing acquired von…
Heavy menstrual bleeding — a frequently reported symptom in women with von Willebrand disease (VWD) — is often overlooked in clinical trial design, eligibility criteria, and outcome measures, a review study finds. For example, traditional clinical trial outcomes for bleeding disorders, such as the annualized bleed rate, failed to…
Latest news & perspectives
Adding Cablivi (caplacizumab-yhdp) to standard treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) may help protect the brain by repairing damage to the blood-brain barrier,…
Blocking the activity of an enzyme known as MELK may help boost the production of platelets — tiny cell fragments that improve blood clotting and…
